Skip to playerSkip to main content
#PharmaTariff #TradeShock #DrugAccessCrisis #GlobalHealthRisk
Transcript
00:00Breaking news and it's a big one. Donald Trump just announced a 100% tariff on imported branded
00:06pharmaceuticals on imported patented pharmaceuticals kicking in October ferns. There's one carve out
00:13if a company is actively building a drug manufacturing plant in the US, they're spared.
00:18This isn't out of nowhere. He's been teasing tariffs for months to push drug makers to bring
00:23production home and secure the medicine supply chain. Eli Lilly just committed billions, Texas,
00:28Virginia. But the shockwave hit immediately. Japan's Topics Pharma downed South Korean
00:32giants red. Hong Kong names like Whoopsy Biologics leading losses. Markets are reading this as a
00:37global restructuring moment. 100% is actually lower than what Trump floated, up to 250% within a year
00:45or so. So today's move could be the starter. Industry response, PHRMA is sounding alarms.
00:51Medicines were usually exempt from tariffs to avoid shortages and cost spikes. Their meth says even
00:56a 25% tariff could add roughly $51 billion a year to US drug costs. At 100% experts warn it could be
01:04disastrous for patients if costs get passed on and supply can't shift quickly. This also isn't a
01:09one-off. Tariffs on cabinets, furniture, big trucks. The message is clear. Rebuild at home or pay. Why it
01:19matters beyond the US. Access to foreign-made drugs could tighten exporters from Europe, exporters from India,
01:25exporters from Australia. Supply chains may rewire inland but that takes years. And medicines aren't iPhones.
01:31What I'm watching next, do companies accelerate US factory timelines to dodge the tariff? Do prices jump
01:37at the pharmacy counter or do insurers and PBMs absorb some of it? Does the administration actually escalate
01:43towards 150% or 250% and do allies push back, risking a pharma trade rift?
Be the first to comment
Add your comment

Recommended